Reaction
Nocturnal Dyspnoea reporting signals
As of the last recalculation, Nocturnal Dyspnoea appears in 1,256 FAERS reports alongside 32 co-occurring drug terms. The strongest observed disproportionality signal is CICLESONIDE (PRR 31.0).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Ciclesonide | 25 | 31.0 | 31.1 |
| Selexipag | 34 | 22.4 | 22.4 |
| Epoprostenol | 16 | 20.5 | 20.5 |
| 0Xygen | 52 | 18.2 | 18.2 |
| Oxygen | 52 | 18.2 | 18.2 |
| Mepolizumab | 49 | 17.0 | 17.0 |
| Tiotropium Bromide Inhalation Spray | 10 | 14.9 | 14.9 |
| Budesonide And Formoterol Fumarate Dihydrate | 80 | 14.5 | 14.5 |
| Riociguat | 27 | 14.0 | 14.0 |
| Fluticasone Propionate And Salmeterol Xinafoate | 48 | 13.7 | 13.7 |
| Umeclidinium | 7 | 13.0 | 13.0 |
| Fluticasone Furoate And Vilanterol Trifenatate | 27 | 12.7 | 12.7 |
| Macitentan | 51 | 12.7 | 12.7 |
| Dronabinol | 6 | 12.4 | 12.4 |
| Sildenafil | 42 | 12.4 | 12.4 |
| Treprostinil | 87 | 12.3 | 12.3 |
| Ticagrelor | 23 | 12.2 | 12.2 |
| Ambrisentan | 83 | 11.7 | 11.7 |
| Eplerenone | 9 | 11.7 | 11.7 |
| Budesonide, Glycopyrrolate, And Formoterol Fumarate | 7 | 11.2 | 11.2 |
| Tadalafil | 56 | 9.7 | 9.7 |
| Tiotropium Bromide | 73 | 9.3 | 9.3 |
| Benralizumab | 11 | 9.2 | 9.2 |
| Bosentan | 27 | 9.0 | 9.1 |
| Umeclidinium Bromide And Vilanterol Trifenatate | 9 | 9.0 | 9.0 |
| Sildenafil Citrate | 64 | 8.7 | 8.7 |
| Omalizumab | 39 | 7.8 | 7.8 |
| Fluticasone Propionate And Salmeterol | 18 | 7.2 | 7.2 |
| Dronedarone | 4 | 6.5 | 6.5 |
| Fluticasone Furoate, Umeclidinium Bromide And Vilanterol Trifenatate | 14 | 5.7 | 5.7 |
| Ravulizumab | 4 | 4.9 | 4.9 |
| Sacubitril And Valsartan | 28 | 4.1 | 4.1 |